PS1149 SECOND CANCER INCIDENCE IN CLL PATIENTS RECEIVING BTK INHIBITORS

Authors :: Seema A. Bhat
John C. Byrd
Amy S. Ruppert
D. Bond
Y. Huang
K. Maddocks
Jennifer A. Woyach
James L. Fisher
D. Owen
S. Jaglowski
Michael R. Grever
Kerry A. Rogers
E. Bertino
Source :: HemaSphere. 3:520-521
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Btk inhibitors
Incidence (epidemiology)
Internal medicine
Medicine
Second cancer
Hematology
business

Full Text Access

Tools